HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 15016

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  


 
ORIGINAL ARTICLE Table of Contents   
Year : 2022  |  Volume : 47  |  Issue : 2  |  Page : 207-212
Impact of steam inhalation, saline gargling, and povidone-iodine gargling on clinical outcome of COVID-19 patients in Bengaluru, Karnataka: A randomized control trial


1 Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India
2 Department of Health and Family welfare, Bruhat Bengaluru Mahanagara Palike, Bengaluru, Karnataka, India
3 Department of Community Medicine, Mysore Medical College and Research Institute, Mysore, Karnataka, India
4 Department of Microbiology, Kempegowda Institute of Medical Science, Bengaluru, Karnataka, India
5 Department of Community Medicine, Bowring and Lady Curzon Medical College and Research Institute, Bengaluru, Karnataka, India

Correspondence Address:
Dr. S Saraswathi
Department of Community Medicine, Bangalore Medical College and Research Institute, K R Road, Fort, Bengaluru - 560 002, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijcm.ijcm_804_21

Rights and Permissions

Context: In the absence of any specific treatment available for COVID-19, people started practicing traditional nonpharmacological preventive home remedies such as salt water gargling and steam inhalation. The available research evidence on some of these measures opines that steam inhalation, saline gargling, and povidone-iodine gargling does have virucidal properties and do provide symptomatic relief. Aims: The aim is to test this hypothesis, and the present trial was undertaken with an objective to assess the effect of steam inhalation, saline gargling, and povidone-iodine gargling among the COVID-19-positive patients with respect to early test negativity and clinical recovery. Methodology: Open-labeled, parallel, randomized controlled trial was conducted among asymptomatic or mild COVID-19-positive patients in Bangalore from September 2020 to February 2021. In each group of steam inhalation, saline gargling, povidone-iodine gargling, and control, twenty participants were allocated. Daily follow-up was done for 21 days to assess early test negativity and clinical recovery. Trial Registry Number: Clinical Trial Registry India/2020/09/027687. Results: Among 80 participants recruited, 65 (81.3%) were symptomatic. Early test negativity was seen in povidone-iodine gargling group of 6 days (KaplanMeier survival curve, BreslowGeneralized Wilcoxon test P = 0.7 as per the intention-to-treat and as per-protocol P = 0.8). Significant clinical recovery was seen in saline gargling group (4 days, P = 0.01). Conclusion: Povidone-iodine gargling was effective in providing early test negativity, whereas saline gargling was effective in early clinical recovery.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed732    
    Printed12    
    Emailed0    
    PDF Downloaded93    
    Comments [Add]    

Recommend this journal

 

  Sitemap | What's New | Copyright and Disclaimer | Privacy Notice
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007